Delonix Bioworks
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Shanghai, Shanghai, ChinaPhone Number
+86 2021005985Website
www.delonixbio.comRevenue
$6.8 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Delonix Bioworks
Based out of Shangai, China, Delonix Bioworks is a biotechnology company with a focus on synthetic biology and vaccines.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Delonix Bioworks your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Delonix Bioworks has recently received funding, and reach out quickly before it becomes old news!
Check out if Delonix Bioworks is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Delonix Bioworks launches new products
Congratulate Masked Content for being promoted to Masked Content at Delonix Bioworks
Funding: Get notified immidiatlly once Delonix Bioworks has new funding data
Delonix Bioworks, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Delonix Bioworks recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Delonix Bioworks had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Delonix Bioworks is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Delonix Bioworks is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Delonix Bioworks.
Delonix Bioworks financials insights
Gather financial insights about Delonix Bioworks, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$14M
Delonix Bioworks Tech Stack
A closer look at the technologies used by Delonix Bioworks
Delonix Bioworks News & Media
Delonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104
SHANGHAI and PERTH, Australia, March 30, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company pioneering genetically engineered bacterial vaccines, today announced the initiation of first-in-human (FIH) dosing in a Phase 1 clinical trial of DX-104. DX-104 is an...Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia
SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received Investigational New Drug (IND) clearance from...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Delonix Bioworks
Sign Up For FreeTo access detailed company insights
Based out of Shangai, China, Delonix Bioworks is a biotechnology company with a focus on synthetic biology and vaccines.... Read More
